Updates are available Correction dated 2020-11-17
Click to view Correction: https://doi.org/10.1007/s00592-020-01617-2
-
Authors
Bhatia, Ashima
Tawade, Shraddha
Mastim, Mushtaque
Kitabi, Eliford Ngaimisi
Gopalakrishnan, Mathangi
Shah, Manish
Yeshamaina, Sridhar
Gobburu, Joga
Sahib, Maharaj
Thakur, Dipak
Prasanna Kumar, K. M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
ctri/2015/06/005890 at Clinical Trials Registry IndiaDocuments that mention this clinical trial
- License Information
-
More Information
Article History
Received: 3 December 2017
Accepted: 1 February 2018
First Online: 16 February 2018
Change Date: 17 November 2020
Change Type: Correction
Change Details: Authors would like to correct the error in table��2 of the online published article.
Compliance with ethical standards
:
: Prasanna Kumar K M is an advisory board member of Wockhardt, Sanofi, Biocon, Novo- Nordisk and Eli Lilly and has conducted clinical research as PI for the insulin analogs for these companies. Shraddha Tawade, Mushtaque Mastim, Manish Shah, Sridhar Yeshamaina, Maharaja Sahib, Dipak Thakur and Ashima Bhatia are employees of Wockhardt Ltd. Eliford Ngaimisi, Mathangi Gopalakrishnan and Joga Gobburu have no conflict of interest to declare.
: The study was conducted in accordance with the declaration of Helsinki and as per the guidelines formulated by the ICH GCP and the Indian Council of Medical Research (ICMR) for biomedical research on human subjects.
: Informed consent was obtained from all individual participants included in the study.
